Sichuan Hebang Biotechnology Co Ltd Net Asset Quality Index
Sichuan Hebang Biotechnology Co Ltd net asset quality index. Sichuan Hebang Biotechnology Co Ltd (603077) has a Net Asset Quality Index of 65.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥29.64 Billion minus total liabilities of CN¥10.30 Billion yields net assets of CN¥19.34 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Sichuan Hebang Biotechnology Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Sichuan Hebang Biotechnology Co Ltd (2009–2025)
Net asset quality index of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025. This chart shows how Sichuan Hebang Biotechnology Co Ltd's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of June 2026, the index stands at 65.3%, representing net assets of CN¥19.34 Billion against total assets of CN¥29.64 Billion CNY. See Sichuan Hebang Biotechnology Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Sichuan Hebang Biotechnology Co Ltd Net Asset Quality Index by Year (2009–2025)
Sichuan Hebang Biotechnology Co Ltd net asset quality index by year from 2009 to 2025. The table below presents the year-by-year Net Asset Quality Index for Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603077 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 63.7% | CN¥17.96 Billion | CN¥28.21 Billion | CN¥10.25 Billion | ▼ -0.4 pp |
| 2024 | 64.1% | CN¥19.01 Billion | CN¥29.65 Billion | CN¥10.64 Billion | ▼ -18.3 pp |
| 2023 | 82.4% | CN¥20.22 Billion | CN¥24.54 Billion | CN¥4.32 Billion | ▲ +0.4 pp |
| 2022 | 82.0% | CN¥19.76 Billion | CN¥24.10 Billion | CN¥4.34 Billion | ▲ +0.3 pp |
| 2021 | 81.7% | CN¥14.64 Billion | CN¥17.92 Billion | CN¥3.29 Billion | ▲ +5.0 pp |
| 2020 | 76.7% | CN¥11.31 Billion | CN¥14.74 Billion | CN¥3.43 Billion | ▼ -2.4 pp |
| 2019 | 79.1% | CN¥11.45 Billion | CN¥14.48 Billion | CN¥3.03 Billion | ▼ -5.2 pp |
| 2018 | 84.3% | CN¥11.20 Billion | CN¥13.29 Billion | CN¥2.09 Billion | ▼ -1.7 pp |
| 2017 | 86.0% | CN¥11.27 Billion | CN¥13.11 Billion | CN¥1.83 Billion | ▲ +2.7 pp |
| 2016 | 83.4% | CN¥10.78 Billion | CN¥12.93 Billion | CN¥2.15 Billion | ▲ +24.6 pp |
| 2015 | 58.8% | CN¥6.58 Billion | CN¥11.20 Billion | CN¥4.62 Billion | ▲ +6.7 pp |
| 2014 | 52.0% | CN¥4.75 Billion | CN¥9.13 Billion | CN¥4.38 Billion | ▼ -6.9 pp |
| 2013 | 58.9% | CN¥3.29 Billion | CN¥5.58 Billion | CN¥2.29 Billion | ▼ -8.5 pp |
| 2012 | 67.5% | CN¥3.40 Billion | CN¥5.05 Billion | CN¥1.64 Billion | ▲ +31.1 pp |
| 2011 | 36.4% | CN¥1.34 Billion | CN¥3.68 Billion | CN¥2.34 Billion | ▲ +5.2 pp |
| 2010 | 31.2% | CN¥974.62 Million | CN¥3.12 Billion | CN¥2.14 Billion | ▲ +8.0 pp |
| 2009 | 23.3% | CN¥737.62 Million | CN¥3.17 Billion | CN¥2.43 Billion | — |